## **Core Concept**
Von Hippel-Lindau (VHL) syndrome is a genetic disorder that predisposes individuals to develop various types of tumors, both benign and malignant. It is characterized by the development of hemangioblastomas in the retina, cerebellum, and spinal cord, as well as an increased risk of certain visceral malignancies. The syndrome is associated with mutations in the VHL gene, which acts as a tumor suppressor.

## **Why the Correct Answer is Right**
The correct answer, **Renal Cell Carcinoma (RCC)**, is linked to VHL syndrome due to the role of the VHL gene in regulating cellular responses to hypoxia. The VHL protein is involved in the ubiquitination and degradation of hypoxia-inducible factor (HIF), a transcription factor that promotes the expression of genes involved in angiogenesis, glucose metabolism, and cell proliferation. Loss of VHL function leads to accumulation of HIF, which in turn increases the expression of vascular endothelial growth factor (VEGF) and other factors that promote tumor growth. Renal cell carcinomas, particularly the clear cell type, are a common manifestation of VHL syndrome.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although hemangioblastomas are associated with VHL syndrome, the question specifically asks about renal neoplasms.
- **Option B:** This option is incorrect as there is no direct association between VHL syndrome and **pheochromocytoma** as a primary renal neoplasm, though pheochromocytomas can occur in the context of VHL.
- **Option C:** This option is incorrect because, while **renal cysts** are indeed associated with VHL syndrome, the question asks for a neoplasm, not a benign cystic lesion.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with VHL syndrome have a high risk of developing **clear cell renal cell carcinoma (ccRCC)**, which is a specific and aggressive subtype of renal cancer. Screening for renal tumors is a crucial part of the management of VHL syndrome.

## **Correct Answer:** D. Renal Cell Carcinoma.